| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Published online before print July 31, 2008
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



From the Departments of Pathology* and Otolaryngology,
University of Pittsburgh and Pittsburgh Veterans Administration Medical Center, Pittsburgh, Pennsylvania; and the Carver Research Foundation,
Tuskegee University, Tuskegee, Alabama
| Abstract |
|---|
|
|
|---|
Our recent findings suggest that this paracrine epithelial-mesenchymal loop is mediated at least in part by ligands for the CXCR3 chemokine receptor. This seven transmembrane classical G-protein-coupled receptor has two isoforms, with the b isoform predominant on adherent cells as opposed to the form on the hematopoietic lineages.3 This CXCR3b binds, seemingly interchangeably, CXC chemokines that lack the ELR (aspartic acid, leucine, and arginine) motif. In addition to functioning in other physiological and pathological processes, all four chemokines appear during wound healing. CXCL4 (PF4) is released by platelets during the initial hemostatic phase,4 with CXCL9 (Mig) being produced during the early inflammatory response.5 The other two ELR-negative CXC chemokines are more intriguing because they appear in the later regenerative phase seemingly preceding the maturation switch. CXCL10 (IP-10) is produced deep in the dermis by the neovascular endothelial cells and in the epidermis.2,6 IP-9 derives from the redifferentiating keratinocytes just behind the leading tongue of re-epithelializing keratinocytes.2,7
What directs us to hypothesize that these two later factors, IP-10 and IP-9, are critical to wound maturation is not only the timing of appearance but the effects of CXCR3 signaling. CXCR3 activation limits the motility induced by classical growth factors of fibroblasts and endothelial cells.7-9 The effect on fibroblasts is to channel the growth factor-induced transcellular contractility to maturation-related matrix compaction.10 Furthermore, not only is CXCR3 signaling angiostatic,9,11 but its activation of µ-calpain (calpain I) leads to vascular disintegration through anoikis (R. Bodnar, manuscript submitted). Importantly, CXCR3 signaling is not inhibitory to dedifferentiated keratinocytes but actually stimulates motility, being additive with growth factors.7,12 Thus, we hypothesized that IP-9 is a key integrator of epidermal and dermal responses, by driving speedy re-epithelialization of the wound simultaneous with directing maturation and strengthening of the dermal wound bed.2 To test this, we have prevented IP-9 expression in keratinocytes during wound repair, by generating transgenic mice in which an antisense construct is driven from the basal keratinocyte-specific cytokeratin K5 promoter.13
| Materials and Methods |
|---|
|
|
|---|
FVB mice were used throughout. The antisense construct was generated by cloning the IP-9 cDNA into the SnaB1 site of the pBK5 vector, which contains 5.2 kb of the bovine cytokeratin K5 promoter (a kind gift from Dr. Jose Jorcano, CIEMAT, Madrid, Spain).13
After verification that this construct could significantly blunt the interferon-
induction of IP-9 in human keratinocytes (Figure 1A)
this was used to generate transgenic mice in the University of Pennsylvania (Philadelphia, PA) transgenic core facility. Founders were identified by germline transmission of the transgene using polymerase chain reaction of tail clip DNA (forward: 5'-CATATGAAGTCCTGGAAAAGGG-3'; reverse: 5'-ACAACTACACCCTGGTCATCA-3'). Mice were sib-mated by transgene x wild type. The transgenic mice are referred to as IP-9AS. In the transgene, IP-9 production was not noted during wound repair (Figure 1B)
.
|
Wounding
Male and female mice (7 to 8 weeks of age weighing
25 g) were anesthetized with an intraperitoneal injection containing ketamine (75 mg/kg) and xylazine (5 mg/kg). The backs were cleaned, shaved, and sterilized with betadine solution. For full thickness wounds, a 2-cm full-thickness wound through the epidermis and dermis was made on one side of the dorsal midline, using sharp scissors, with the contralateral uninjured skin serving as a control. Partial-thickness wounds were made with a specially-modified dermatome.14
The wounds were covered with liquid occlusive dressing (New-Skin; Medtech, Jackson, WY). This experiment was performed in duplicate.
To follow the wound progression visually, the animals were lightly anesthetized for several seconds with a halothane cone. A transparent sheet was placed over the wound. Re-epithelialization of the wound was traced at 2-day intervals until complete closure. These parameters were compared between the wild-type and IP-9AS. The tracings were measured using Adobe Photoshop image analysis software (version 7.0; Adobe System Inc., San Jose, CA).
Histological Analyses
Wound bed biopsies, including a margin of nonwounded skin, were collected at days 5, 7, 14, 21, 30, and 60 after wounding. Wound biopsies were fixed in 10% buffered formalin, processed, and embedded in paraffin blocks using standard protocols. Four-µm tissue sections were stained with hematoxylin and eosin (H&E) for assessment of general tissue and cellular morphology. Collagen deposition, content, and alignment were evaluated by Massons Trichrome and Picrosirius Red staining. Slides were quantitatively analyzed using MetaMorph (Universal Imaging Corp., Molecular Devices, West Chester, PA). The histological scoring system was developed based on the scoring system by Greenhalgh.15 Most of the scoring systems use more than one determinant to assess the histological parameters, as briefly described below.
Inflammation
Acute inflammation was defined as the presence of neutrophils and chronic inflammation by the presence of plasma and monocytic cells (0, none; 1, slight; 2, moderate; 3, abundant). In both situations the scale was secondary to relative level of cells per high-power field.
Epidermal and Dermal Maturation
Histopathological examination of mouse tissues was performed blinded by a trained histopathologist. Qualitative assessments were made concerning aspects of dermal and epidermal maturation, inflammation, and granulation tissue. The samples were scored on a scale of 0 to 4 for epidermal healing (0, no migration; 1, partial migration; 2, complete migration with partial keratinization; 3, complete keratinization; and 4, normal epidermis) and dermal healing (0, no healing; 1, inflammatory infiltrate; 2, granulation tissue present—fibroplasias and angiogenesis; 3, collagen deposition replacing granulation tissue >50%; and 4, complete healing).
Collagen Content
Massons trichrome staining was used to assess collagen content as previously described by Yates and colleagues.2 Collagen content was assessed using MetaMorph analysis (Molecular Devices, Sunnyvale, CA), Stained wound biopsies were compared with that of the unwounded controls: at all times the colors was maintained to compare the blue- and red-stained areas. The final output was integrated intensity based on total area and staining intensity at individual pixels. All wound biopsies were stained at the same time to eliminate staining variation.
Collagen Alignment and Organization
Picrosirius Red staining was used to assess alignment and organization in intact biopsies. Briefly, picric acid (Sigma-Aldrich, St. Louis, MO) was dissolved in 500 ml of distilled water. To this, 0.1 g of Sirius Red F3BA was added per 100 ml (Sigma-Aldrich). Paraffin-embedded tissue sections were rehydrated and stained with picric acid. Collagen fibrils were then evaluated by means of polarized light microscopy for both collagen fibril thickness and coherence alignment. Polarization microscopy reveals closely packed thick fibrils of type I collagen fibers as either red-orange intense birefringence in the hypertropic tissue, with thin short loose fibrils as yellow-green. Distribution of fibrils in terms of thickness (cross-sectional area) and arrangement in terms of length of the collagen scars were quantitatively analyzed using Meta-Morph (Molecular Devices). Biopsies of unwounded skin served to set the threshold against which the wound biopsies were measured. Percent staining of mature fibers was determined by comparing the total staining intensity of the birefringence (area of staining summed for intensity of pixel) of wound biopsies compared with the biopsies of the contralateral unwounded skin.2
Immunohistochemistry
Sections for immunohistochemical analysis were incubated with appropriately diluted primary antibody, after antigen retrieval. Antigen staining was performed using diaminobenzidine (Vector Laboratories, Burlingame, CA), then counterstained with Mayers hematoxylin and coverslipped. In all cases, secondary antibody alone served as a negative control, with various tissues serving as positive controls.
Paraffin sections of 4 to 5 µm were prepared for antibody staining. The following antibodies were used for immunohistochemical staining for mouse: fibronectin (rabbit polyclonal; Rockland, Inc., Gilbertsville, PA), IP-9 (goat polyclonal; Santa Cruz Biotechnology, Santa Cruz, CA), tenascin-C (rat polyclonal; R&D Systems, Minneapolis, MN), collagen IV (rabbit polyclonal; Abcam Inc., Cambridge, MA), and Ki-67 (rabbit polyclonal, Abcam Inc.).
Tensile Strength
Biopsies were wrapped flat in foil, snap-frozen in liquid nitrogen, and then stored at –80°C. For the tensile strength measurements, the frozen specimens were divided into two samples, the cross-sectional area measured with calipers, and then the samples were clamped in a tensiometer and force-exerted until wound disruption, as previously described.14 The tensiometer was calibrated after every third sample with a wide range of weights. Measurements were recorded by a customized computer software program and tensile strength calculated using the formula: maximum tensiometer reading (converted to g) divided by cross-sectional area (mm2) = tensile strength (g/mm2). The results for individual specimens from one wound were combined to determine an average tensile strength per wound. The average tensile strength per wound was tabulated for each group at days 7, 14, 21, 30, and 60 after wounding.
In Situ Hybridization
Pspt 18 plasmid (Roche Molecular Diagnostics, Indianapolis, IN) harboring the IP-9 sequence6 in either orientation were linearized and Digoxigenin DIG labeled. Sense (control) and anti-sense RNA probes were obtained by using the DIG labeling RNA kit (Roche Molecular Diagnostics, Indianapolis, IN) with SP6 RNA polymerase. Labeled probes were purified by the Qiagen (Valencia, CA) spin column kit. In situ hybridization was performed on formalin-fixed, paraffin-embedded wound biopsy sections from different days as described previously. These were overlaid with 100 µl of hybridization buffer containing 100 ng of probe and incubated overnight at 37°C in a humidified chamber. After hybridization, nonhybridized probe were removed using high stringency washes. The sections were incubated with anti-DIG-labeled secondary antibody conjugated with alkaline phosphatase. Staining reaction was performed using BCIP/NBT substrate and photographed.
Statistical Analysis
Results are expressed as mean ± SD. Statistical differences between groups were determined by the 2 tailed Students t-test. Paired analyses were performed between all groups. Comparisons throughout time were performed by analysis of variance. Significance is deemed at P < 0.05.
| Results |
|---|
|
|
|---|
Keratinocytes produce IP-9 in response to wounding both in vitro and in vivo.2,7
IP-9 mRNA is detectable just behind the leading edge of the wound (Figure 1C)
. Protein is noted in murine wounds as early as day 4 and expression persists as late as day 16.2
Because IP-9 expression during wound repair appears mainly limited to the dedifferentiated keratinocytes of the epidermis we sought to specifically ablate such production in mice using a promoter that is highly active in the dedifferentiated keratinocytes, the cytokeratin K5 promoter (Figure 1B)
.16
The pathophysiological effects of the suppression of IP-9 during healing were determined by creating full and partial thickness excisional wounds in the dorsal skin on the IP-9AS and FVB (wild type) mice. Grossly in partial thickness wounds, a delay in healing was observed in the IP-9AS mice with the eschar being present at least 14 days longer than in the wild-type mice (Figure 2)
. In the full thickness wounds, the gross deficits were more subtle (data not shown). This was not unexpected because full thickness skin wounds in rodents close mainly by contraction15
; furthermore, deep in the dermis, CXCL10/IP-10 appears to be the predominant CXCR3 ligand.2,17
|
Analyzed histologically, the wounds in the IP-9AS mice showed both a delayed re-epithelialization and an immature epidermis. In partial thickness wounds, the progressing keratinocyte tongue was delayed (Figure 3A)
, and even where the underlying dermis was covered, the epidermal layer was thicker (Figure 3B)
with more transit-amplifying cells even as long as 30 days after wounding at which time the wounds in wild-type mice appear fully healed. Even in the wild-type mice, the wounds at 30 days are not similar to unwounded skin, although they do demonstrate significant wound maturation; this level of maturation is significantly less in the wounds in the IP-9AS mice. This correlates with the corresponding increase in the number of cell layers that constitute the epidermis in the IP-9AS wounds (0.0202 mm in IP-9AS versus 0.0080 mm in the FVB mice) (Figure 3C)
.
|
Dermal Healing Is Limited in the Suppression of IP-9 Signaling
Fibroplasia and epithelialization are two distant aspects of the skin healing, both of which appear impacted by CXCR3 signaling.2
It has been speculated that keratinocyte-derived soluble factors signal the maturation of the underlying dermis to synchronize the wound repair.18
Even in full thickness wounds, dermal maturation was delayed up to 60 days after wounding (Figure 4A)
. Masson trichrome staining for collagen content shows a clear morphological difference in the dermal matrix with the wounds in IP-9AS mice having less deposited collagen and greater fibroblast cellularity in comparison to wounds in FVB control mice (Figure 4, B and C)
. Quantification of the dermal wounds revealed that IP-9AS mice failed to properly remodel the dermal matrix as late as day 60 after wounding; Picrosirius Red staining showed that the IP-9AS wounds had shorter and less well connected collagen fibers resulting in a less well organized with respect to regain of tensile strength and immature scar (Figure 4, D and E)
. Consistent with the collagen immaturity, provisional matrix components including tenascin C and fibronectin are not present at day 21 (tenascin C) and day 14 (fibronectin) in the wounds of IP-9AS mice in comparison to wild type (Figure 4F)
.
|
In the partial thickness wounds, the superficial, papillary dermis was removed by the dermatome.14
In this region, dermal repair was deficient in IP-9AS wounds, showing collagen and matrix immaturity. Importantly for skin healing, the delineating basement membrane between the dermal and epidermal compartments was deficient. Most obvious, is the elevated expression of collagen IV (Figure 5)
in the late healing phase of the IP-9AS mice suggesting that the epidermis-dermal junction has yet to properly form, resulting in a looser connection between these layers in the healed wounds of the IP-9AS mice (Figure 3B)
.
|
The first aspect of wound healing after hemostasis involves an inflammatory response with a rapid infiltration of polymorphonuclear leukocytes (acute response) followed by macrophages and lymphocytes (chronic response). This is thought to be crucial to re-establishing the microbial barrier function of the skin. Interestingly, although CXCR3 ligands limit migration of stromal and endothelial cells, they are chemotactic for hematopoietic cells.19
As such it was critical to determine whether the lack of the epidermally-derived IP-9 blunted this response. Unexpectedly, the presence of polymorphonuclear (Figure 6A)
and mononuclear (Figure 6B)
leukocytes was similar in wounds of both FVB and IP-9AS mice when determined by histopathological analyses. Thus, the differences in dermal and epidermal maturation noted above were not because of differences in the early inflammatory infiltrations.
|
| Discussion |
|---|
|
|
|---|
Our model postulated that suppression of IP-9 expression would result in delayed wound maturation, particularly in the epidermal and superficial dermal compartments, similar to that noted in wounds in the CXCR3-devoid animals.2 We abrogated IP-9 production in mice by expressing an antisense construct from the cytokeratin K5 promoter that is active in proliferative basal keratinocytes,22,23 the cells that transcribe the IP-9 gene. This resulted in a mouse in which IP-9 production was absent from skin wounds. Wounding of these mice resulted in a persistent hypercellular wound and delayed maturation of the compartments similar to that seen in wounds in the CXCR3-devoid mice. These finding are consistent with the underlying molecular mechanisms whereby CXCR3 signaling i) limits fibroblast and endothelial cell motility by preventing µ-calpain activation by motogenic growth factors such as EGF, PDGF, and VEGF8,9,24 ; ii) channels wound bed signals toward matrix contraction and reorganization by fibroblasts10,25 ; and iii) induces endothelial cell apoptosis via a µ-calpain-mediated process (R. Bodnar, manuscript submitted). The absence of these stop immigration and involution, at least for endothelial cells, and maturation, at least for fibroblasts, signals should result in hypercellular wounds with persistent expression of provisional matrix components, as is noted. Contrarily, we also had found that CXCR3 signaling promotes keratinocyte motility and coverage of a monolayer gap by µ-calpain activation reducing adhesiveness to shift these cells toward a more favorable regime for motility.7,12 We found that re-epithelialization appeared delayed even in these full-thickness wounds. However, full-thickness wounds in rodents close primarily by contraction because the skin is only loosely connected to the underlying integumen in distinction to the human situation. For this reason, we created partial thickness wounds using a specially modified dermatome that removed the epidermis and only the superficial dermis.14 These wounds were re-epithelialized from the margins, in a situation more relevant to wound healing in humans. Examining these wounds, we found that re-epithelialization was somewhat delayed, consistent with IP-9 signaling motility, although to a less degree than classical growth factors present in the wound.7 What was more striking was the hypertrophic epidermis and the immaturity of the underlying basement membrane. This would imply that the IP-9/CXCR3 signaling access, although being a minor player in keratinocyte migration, might play a major role in signaling the wound resolution stage. Whether the two aspects of epidermal cellularity and basement membrane construction are related, and if so, in which hierarchical status, remains to be determined in future studies that lie beyond the scope of the present communication.
An aspect of wound healing that has remained enigmatic despite extensive investigation is the initial exuberant inflammatory response. Intuitively such a response would be needed when the main barrier to external microbes is breached as in a skin wound. However, there is also evidence that such an inflammatory response, particularly if prolonged or exaggerated, leads to scarring; fetal wounds that regenerate lack this inflammatory response. Thus, a fine balance must be maintained between battling infection and limiting damage to the surrounding regenerating tissues. A number of factors are present immediately after wounding that attract the innate immune response first followed by the cells of the acquired immune response, among these the CXCR3 ligands are chemoattractants for these cells.26 It is most likely that PF4 and MIG play a greater role in recruiting these cells because of their appearance much earlier in wound healing at times of greatest inflammatory response. However, there is still the open question of whether the lack of IP-9 production by keratinocytes would compromise the inflammatory response after the first week. We did not note a deficit in the inflammatory response at the crude level of histopathological analyses. In fact, in initial analyses of wounds in mice lacking CXCR3, and thus eliminating the signals from PF4 and MIG also, we do not see a difference in the histology of the inflammatory response (data not shown). This would imply that many other factors, not limited to the other CXCR3 ligands, regulate the important function of preventing wound contamination and infection. However, it must be noted that these wounds were created under clean conditions in which the inflammatory response is not stressed; contaminated wounds might show much greater differences in healing outcomes in the suppression of IP-9 or more importantly all CXCR3 signaling. Furthermore, because IP-9 is up-regulated during dermal immune disorders,27 the relationship between this chemokine and acquired immunity awaits further investigation.
Herein, are presented data that implicate IP-9 as a key communicator between the epidermis and dermis to regulate wound maturation during the late regenerative and resolution phases of healing. The similarly of wounds in mice lacking just IP-9 production by keratinocytes to those in mice in which all CXCR3 signaling is absent because of gene deletion,2,28 suggests that IP-9 is the main chemokine for wound maturation. This would imply that premature IP-9 expression or exogenous addition might arrest wound healing. In usual circumstances this would lead to adverse conditions of weak wounds prone to ulceration. However, there are situations one could envision that would limit scarring or slow healing to allow sequential reconstruction.
| Acknowledgements |
|---|
| Footnotes |
|---|
Supported by the National Institutes of Health (National Institute of General Medical Science grant GM063569) and the Pittsburgh Veterans Administration Medical Center.
Current address of A.Y.: Wayne State University, Detroit, MI; and P.K.: University of Michigan, Ann Arbor, MI.
Accepted for publication June 2, 2008.
| References |
|---|
|
|
|---|
, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. Am J Pathol 1998, 153:1849-1860
, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. Am J Pathol 1998 Dec, 153(6):1849-1860This article has been cited by other articles:
![]() |
R. J. Bodnar, C. C. Yates, M. E. Rodgers, X. Du, and A. Wells IP-10 induces dissociation of newly formed blood vessels J. Cell Sci., June 15, 2009; 122(12): 2064 - 2077. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |